 Members | Associate Members | Membership | Committees | Symposium | Feature Article | Recent Publications | Seminars | Links |
| Welcome |
| Announcements/ News |
| Funding Opportunities |
| CTSA |
| Educational Programs |
| CTRC |
| Centers |
| Programs |
| Cores |
| Contact Us |
| Home |
| ITMAT Glossary |
 |
Emma A. Meagher, MD Associate Professor of Medicine and Pharmacology Associate Director, Cardiovascular Risk Program Executive Chair, Institutional Review Board Director, ITMAT Educational Programs Course Director, Clinical Pharmacology, Dept of Pharmacology Institute for Translational Medicine and Therapeutics |
| Education: | ||
| 1981-1987 | Royal College of Surgeons, Dublin, Ireland MB (M.D.) | |
|
Research Summary: Dr. Meagher's area of research interest includes mechanisms of vascular dysfunction in cardiovascular disease, alcohol induced liver disease and the role of antioxidant vitamin therapy in both primary and secondary prevention of disease. Dr. Meagher's interests is also in the field of oxidant injury in atherosclerosis. Her clinical practice is in the area of cardiovascular risk modification with an emphasis on management of dyslipidemia, hypertension and women's cardiovascular health. Selected Key Publications: Meagher EA, Barry OP, Lawson J, Rokach J. FitzGerald GA. Effects of Vitamin E on Lipid Peroxidation in Healthy Volunteers. JAMA 285(9)1178-1182, 2001. Burke, A., Lawson, J., Meagher, E., Rokach, J., FitzGerald, G.: Specific Analysis in Plasma and Urine of 2,3-Dinor-5,6-Dihydro-iPF2α -III (2,3-Dinor-iPF1α -III), a Metabolite of iPF2α -III, and an Oxidation Product of -Linolenic Acid. J Biol Chem. 275(4):2499-2504, 2000. Meagher, E.A., Barry, O.P., Burke, A., Lucey, M., Rokach, J. and FitzGerald,G.A.: Alcohol induced generation of lipid peroxidation products in humans. J. Clin. Invest. 104(6): 805-813, 1999. Reilley, M.P., Moran, N., Meagher, E.A., Delanty, N., Cucchiara, A.E., Lawson, J.A. and Catella-Lawson, F. A randomized, placebo-controlled, crossover study of E5510 and aspirin in healthy volunteers. J. Cardiovasc. Pharm. 33(1):12-18, 1999. Catella, F., Reilly, M.P., Meagher, E.A., Moran, N., Delanty, N., Lawson, J.A. and FitzGerald, G.A. Physiological formation of 8-epi PGF2a in vivo is not affected by cyclooxygenase inhibition. Adv. Prost. Throm. Leuk. Res. 23:233-6, 1995. Meagher, E.A., Grace, P.A. and Bouchier-Hayes, D. Are CT infarcts a separate risk factor in patients with transient cerebral ischaemic episodes. Eur. J. Vasc. Surg. 5:165-7, 1991. Williams, N.N., Broe, P.J., Burke, P., Meagher, E.A., O'Donoghue, C., Otridge, B. and Bouchier-Hayes, D. Heparin kinetics in vascular surgery. Eur. J. Vasc. Surg. 3:493-6, 1989. Meagher EA, Barry OP, Lawson J, Rokach J, FitzGerald GA. Effects of Vitamin E on Lipid Peroxidation in Healthy persons. JAMA 285(9): 1178-1182, 2001. Wolfe ML, Vartanian SF, Ross JL, Bansavich LL, Mohler ER, Meagher EA, Friedrich CA, Rader DJ. Safety and effectiveness of Niaspan when added sequentially to a statin for the treatment of dyslipidemia. Am J. Cardiol. 2001 Feb 15;87(4):476-9. Meagher EA. Cardiovascular and renovascular implications of COX-2 inhibition. Current Pharmaceutical Design. Curr Pharm Des. 2004;10(6):603-11. Meagher EA. Addressing Cardiovascular Disease in Women: A focus on Dyslipidemia. Journal of the American Board of Family Practice. J Am Board Fam Pract. 2004 Nov-Dec;17(6):424-37. Review. Awards, Honors, Membership in Honorary Societies:
|
 University of Pennsylvania | School of Medicine |